2,4-thiazolidinedione has been researched along with Chronic Disease in 3 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "2% troglitazone was administered from 1 month to 7 months of age in WBN/Kob rats with spontaneous chronic pancreatitis." | 3.71 | Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis. ( Fujiwara, T; Hayashi, N; Horikoshi, H; Kobayashi, M; Shimizu, K; Shiratori, K, 2002) |
| "The development of liver fibrosis was reduced in rats receiving TGZ, as indicated by significant decreases of procollagen type I gene expression and liver hydroxy-proline levels." | 1.33 | Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. ( DeFranco, R; Efsen, E; Lottini, B; Marra, F; Novo, E; Parola, M; Pastacaldi, S; Pinzani, M; Robino, G; Spirli, C; Strazzabosco, M; Vercelli, A; Zamara, E, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marra, F | 1 |
| DeFranco, R | 1 |
| Robino, G | 1 |
| Novo, E | 1 |
| Efsen, E | 1 |
| Pastacaldi, S | 1 |
| Zamara, E | 1 |
| Vercelli, A | 1 |
| Lottini, B | 1 |
| Spirli, C | 1 |
| Strazzabosco, M | 1 |
| Pinzani, M | 1 |
| Parola, M | 1 |
| Aoki, Y | 1 |
| Kawa, S | 1 |
| Kiyosawa, K | 1 |
| Shimizu, K | 1 |
| Shiratori, K | 1 |
| Hayashi, N | 1 |
| Kobayashi, M | 1 |
| Fujiwara, T | 1 |
| Horikoshi, H | 1 |
1 review available for 2,4-thiazolidinedione and Chronic Disease
| Article | Year |
|---|---|
[Chronic liver diseases].
Topics: Chronic Disease; Contraindications; Diabetes Mellitus; Humans; Insulin Resistance; Liver; Liver Cirr | 2000 |
2 other studies available for 2,4-thiazolidinedione and Chronic Disease
| Article | Year |
|---|---|
Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis.
Topics: Animals; Bile Ducts; Cell Division; Cholestasis; Chronic Disease; Disease Models, Animal; Hypoglycem | 2005 |
Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis.
Topics: Amylases; Animals; Antineoplastic Agents; Blood Glucose; Chromans; Chronic Disease; Disease Models, | 2002 |